DealsMay 5, 2026, 09:02 AM
HeartSciences signs first revenue-generating MyoVista Insights deal
AI Summary
HeartSciences Inc. announced a commercial agreement with St. Vincent Health to deploy its MyoVista Insights™ platform. This marks the company's first mainstream revenue-generating deployment for the SaaS-based ECG management platform, building on previous early adopter installations. The MyoVista Insights platform is designed to enhance workflow efficiency, provide EHR interoperability, and integrate AI-ECG algorithms into clinical workflows. HeartSciences anticipates securing additional commercial agreements in the coming quarters.
Key Highlights
- HeartSciences signed a commercial agreement with St. Vincent Health.
- The agreement is for the deployment of the MyoVista Insights™ platform.
- This marks the first mainstream revenue-generating deployment for the platform.
- MyoVista Insights operates on a SaaS-based recurring revenue model.
- The platform is cloud-native, device-agnostic, and integrates AI-ECG algorithms.
- HeartSciences expects further commercial agreements in upcoming quarters.